In 2016, BioBridge Global and GenCure led a team including the U.S. Army Institute of Surgical Research and biotech firms Rooster Bio (based in Maryland) and StemBioSys (based in San Antonio), which was awarded a $7.8-million contract from the Medical Technology Enterprise Consortium (MTEC)…
News
- GenCure Opens BioManufacturing Center for Large-Scale Production of Adult Stem Cells to ...
- San Antonio's Bioscience-Medicine Industry Could Help Solve City's Top Health Problems
Working to leverage the city's biomedical assets, like locally-based research and hospitals, the plan aims to fuel economic growth and harness San Antonio's strengths to become a global healthcare resource. What is the impact of healthcare and bioscience on San Antonio's economy? How can the…
- Celgene, Dave & Buster's slide while Kohl's and Crocs rise
The biotech drugmaker said it will buy Impact Biomedicines for $1.1 billion, with up to $5.9 billion in other potential payments. NuVasive Inc., down $5.45 to $55.56. The spinal device maker gave a disappointing forecast for 2018. Crocs Inc., up $1.03 to $13.23. The shoe company raised its sales…
- GenCure expansion to bolster SA role in regenerative medicine
GenCure has begun work on a significant expansion that will greatly enhance the scope of the San Antonio-based company's work in the cellular ... That's created concerns in the biotech industry as Capp said research is outpacing the build up of brick-and-mortar support needed to advance the…
- Novo Nordisk revises up offer for Ablynx to $3.1 billion
HELSINKI (AP) — Danish drugmaker Novo Nordisk has revised up its offer for Belgian biotech company Ablynx as it looks to find growth opportunities beyond its core business. The Copenhagen-based company said Monday it is offering up to 30.50 euros for each Ablynx share, valuing the company at…